Drug comparisons
Glimepiride vs Troglitazone
Glimepiride stimulates insulin release while Troglitazone enhances insulin sensitivity. Both treat type 2 diabetes, but Troglitazone was withdrawn due to liver toxicity.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when evaluating sulfonylureas versus thiazolidinediones for patients with type 2 diabetes.
Bottom line
Glimepiride and Troglitazone are both effective for managing type 2 diabetes but should be used under medical supervision.
All medication comparisons